Table: Kaken Pharmaceutical -2017/18 group results

KAKEN PHARMACEUTICAL

09/05/2018 05:30

May 9 (Reuters)- 
          Kaken Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           98.43          101.48          94.80        47.80    
               (-3.0 pct)      (-7.5 pct)     (-3.7 pct)    (-4.1 pct) 
  Operating       27.50           30.71          22.50        11.70    
               (-10.5 pct)     (-12.6 pct)    (-18.2 pct)  (-23.7 pct) 
  Recurring       27.85           30.98          22.80        11.90    
               (-10.1 pct)     (-12.4 pct)    (-18.1 pct)  (-23.3 pct) 
  Net
  Net             19.04           22.02          16.40         8.30    
               (-13.5 pct)     (+4.1 pct)     (-13.9 pct)  (-23.6 pct) 
  EPS          470.54 yen      536.70 yen     406.75 yen    205.86 yen 
  Ann Div      150.00 yen      150.00 yen     150.00 yen               
  -Q2 Div       75.00 yen       75.00 yen      75.00 yen               
  -Q4 Div       75.00 yen       75.00 yen      75.00 yen               
  
  NOTE - Kaken Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T